As we witness the rapidly climbing number of cases of coronavirus disease 2019 (COVID-
19), clinical trials are underway for monoclonal antibody treatments and a handful of …

As of June 2022, more than 530 million people worldwide have become ill with coronavirus
disease 2019 (COVID-19). Although COVID-19 is most commonly associated with …

The COVID-19 pandemic has triggered intensive research and development of drugs and
vaccines against SARS-CoV-2 during the last two years. The major success was especially …

SARS‐CoV‐2 infection has now become the world's most significant health hazard, with the
World Health Organization declaring a pandemic on March 11, 2020. COVID‐19 enters the …

Despite the scientific and human efforts to understand COVID-19, there are questions still
unanswered. Variations in the metabolic reaction to SARS-CoV-2 infection could explain the …

Abstract Coronavirus disease (COVID-19) outbreak has caused unprecedented global
disruption since 2020. Approximately 238 million people are affected worldwide where the …

Abstract After the World Health Organization declared coronavirus disease 2019 (COVID-
19), as a global pandemic, global health workers have been facing an unprecedented and …

The novel coronavirus 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has made a wide range of manifestations. In this regard …

The first corona-pandemic, coronavirus disease 2019 (COVID-19) caused a huge health
crisis and incalculable damage worldwide. Knowledge of how to cure the disease is urgently …

The mitogen-activated protein kinase (MAPK) p38α is a central component of signaling in
inflammation and the immune response and is, therefore, an important drug target. Little is …